Study: lncRNA ZNF593-AS inhibits cardiac hypertrophy and myocardial remodeling by upregulating Mfn2 expression

by Higher Education PressCredit: Xiang Nie, Jiahui Fan, Yanwen Wang, Rong Xie, Chen Chen, Huaping Li, Dao Wen WangResearchpresentedinFrontiers of Medicinedelves into the regula

Updated on: September 07,2024 0

Study: lncRNA ZNF593-AS inhibits cardiac hypertrophy and myocardial remodeling by upregulating Mfn2 expression

by Higher Education PressCredit: Xiang Nie, Jiahui Fan, Yanwen Wang, Rong Xie, Chen Chen, Huaping Li, Dao Wen WangResearchpresentedinFrontiers of Medicinedelves into the regula

Updated on:September 07,2024 0

Scientists discover a new cardiovascular risk factor and identify a drug able to reduce its effects

by Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)Summary of main findings by CNIC researchers. Clonal hematopoiesis and the expansion of blood cells carrying certain acquired

Updated on: September 06,2024 0

Scientists discover a new cardiovascular risk factor and identify a drug able to reduce its effects

by Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)Summary of main findings by CNIC researchers. Clonal hematopoiesis and the expansion of blood cells carrying certain acquired

Updated on:September 06,2024 0

Research team discovers how Copaxone protects the heart muscle and improves its function after heart attack

byWeizmann Institute of ScienceCardiac sections of mice after an injury simulating a heart attack. In mice that were treated with Copaxone (bottom row), the sections reveal greater integrity of

Updated on: September 06,2024 0

Research team discovers how Copaxone protects the heart muscle and improves its function after heart attack

byWeizmann Institute of ScienceCardiac sections of mice after an injury simulating a heart attack. In mice that were treated with Copaxone (bottom row), the sections reveal greater integrity of

Updated on:September 06,2024 0

Digital consultations found to improve the rate at which heart failure patients receive optimal medication

byAmsterdam University Medical CentersCredit: Unsplash/CC0 Public DomainPatients with heart failure, a condition affecting more than 60 million worldwide, are four times more likely to receive t

Updated on: September 06,2024 0

Digital consultations found to improve the rate at which heart failure patients receive optimal medication

byAmsterdam University Medical CentersCredit: Unsplash/CC0 Public DomainPatients with heart failure, a condition affecting more than 60 million worldwide, are four times more likely to receive t

Updated on:September 06,2024 0

Novel low-dose 3-in-1 blood pressure pill significantly outperforms standard care, study shows

byGeorge Institute for Global HealthCredit: Pixabay/CC0 Public DomainNew research shows that a treatment plan based on a novel combination of low doses of three anti-hypertensive drugs in a sing

Updated on: September 06,2024 0

Novel low-dose 3-in-1 blood pressure pill significantly outperforms standard care, study shows

byGeorge Institute for Global HealthCredit: Pixabay/CC0 Public DomainNew research shows that a treatment plan based on a novel combination of low doses of three anti-hypertensive drugs in a sing

Updated on:September 06,2024 0

Vutrisiran offers a new lifeline to patients with progressive heart condition

byEuropean Society of CardiologyCredit: Unsplash/CC0 Public DomainVutrisiran significantly improved mortality, cardiovascular events and markers of disease progression in patients with transthyr

Updated on: September 06,2024 0

Vutrisiran offers a new lifeline to patients with progressive heart condition

byEuropean Society of CardiologyCredit: Unsplash/CC0 Public DomainVutrisiran significantly improved mortality, cardiovascular events and markers of disease progression in patients with transthyr

Updated on:September 06,2024 0

Is long-term beta-blocker therapy needed after a heart attack?

byEuropean Society of CardiologyCredit: Pixabay/CC0 Public DomainThe cardiovascular safety of an interrupting beta-blocker could not be shown in comparison to continuation in patients with a his

Updated on: September 06,2024 0

Is long-term beta-blocker therapy needed after a heart attack?

byEuropean Society of CardiologyCredit: Pixabay/CC0 Public DomainThe cardiovascular safety of an interrupting beta-blocker could not be shown in comparison to continuation in patients with a his

Updated on:September 06,2024 0

AI-based tongue imaging could help enable non-invasive detection of coronary artery disease

by Stephanie Baum , Medical XpressThe tongue diagnosis instrument and collection process. 1: lens hood, 2: LED light resource, 3: high-definition camera, 4: chin support plate. Note. Use fixed standar

Updated on: September 05,2024 0

AI-based tongue imaging could help enable non-invasive detection of coronary artery disease

by Stephanie Baum , Medical XpressThe tongue diagnosis instrument and collection process. 1: lens hood, 2: LED light resource, 3: high-definition camera, 4: chin support plate. Note. Use fixed standar

Updated on:September 05,2024 0

Urban noise pollution may impact cardiovascular risk prediction and prognosis after a heart attack

byEuropean Society of CardiologyCredit: Unsplash/CC0 Public DomainResearch from two studies in different European cities highlights that urban noise pollution has a significant negative impact o

Updated on: September 05,2024 0

Urban noise pollution may impact cardiovascular risk prediction and prognosis after a heart attack

byEuropean Society of CardiologyCredit: Unsplash/CC0 Public DomainResearch from two studies in different European cities highlights that urban noise pollution has a significant negative impact o

Updated on:September 05,2024 0

Semaglutide reduces risk for major adverse cardiovascular events in patients with obesity and heart failure

by Elana GotkineSemaglutide reduces the risk for major adverse cardiovascular events (MACE) and composite heart failure end points compared with placebo in patients with overweight or obesity and hear

Updated on: September 05,2024 0

Semaglutide reduces risk for major adverse cardiovascular events in patients with obesity and heart failure

by Elana GotkineSemaglutide reduces the risk for major adverse cardiovascular events (MACE) and composite heart failure end points compared with placebo in patients with overweight or obesity and hear

Updated on:September 05,2024 0

Cardiovascular disease disproportionately affects middle-income countries, finds study

byEuropean Society of CardiologyCredit: Pixabay/CC0 Public DomainCardiovascular disease (CVD) remains the most common cause of death across Europe, but while CVD mortality rates are generally de

Updated on: September 05,2024 0

Cardiovascular disease disproportionately affects middle-income countries, finds study

byEuropean Society of CardiologyCredit: Pixabay/CC0 Public DomainCardiovascular disease (CVD) remains the most common cause of death across Europe, but while CVD mortality rates are generally de

Updated on:September 05,2024 0

Women with endometriosis at greater associated risk of heart attack and stroke, research finds

byEuropean Society of CardiologyCredit: Sora Shimazaki from PexelsAccording to research presented atESC Congress 2024, women with endometriosis have a 20% greater risk of significant cardi

Updated on: September 05,2024 0

Women with endometriosis at greater associated risk of heart attack and stroke, research finds

byEuropean Society of CardiologyCredit: Sora Shimazaki from PexelsAccording to research presented atESC Congress 2024, women with endometriosis have a 20% greater risk of significant cardi

Updated on:September 05,2024 0